Implementing SPRINT targets can save more than 100,000 lives each year

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway 

  • If all eligible US patients were treated to the Systolic Blood Pressure Intervention Trial (SPRINT) targets, a predicted 107,500 lives each year might be saved.
  • But there is a predicted increase in serious adverse events (SAE), including 88,700 cases of acute kidney injury (AKI).

Why this matters  

  • SPRINT famously produced a 27% decrease in mortality in its selected patient population.
  • SPRINT-eligible patient are at high cardiovascular risk but not have stroke, heart failure, or diabetes.
  • About 17 million adults in the US might be eligible, but 9 million are not even being treated for hypertension.
  • Most “real-world” patients do not fit SPRINT criteria.

Study design

  • Mortality and SAE rates in SPRINT-eligible participants (SE; n=2185) from National Health and Nutrition Examination Survey (NHANES) were evaluated and predictions calculated for patients with criteria for SPRINT-applied (SA).
  • Funding: None.

Key results

  • Overall mo...